PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-0.56%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$15.7M
AUM Growth
-$1.33M
(-7.8%)
Cap. Flow
-$983K
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
174
Closed
55
Top Buys
| 1 |
DexCom
DXCM
|
$67.2K |
| 2 |
Penumbra
PEN
|
$64.7K |
| 3 |
Meta Platforms (Facebook)
META
|
$55.7K |
| 4 |
Becton Dickinson
BDX
|
$55.2K |
| 5 |
GitLab
GTLB
|
$51.5K |
Top Sells
| 1 |
Ferguson
FERG
|
$877K |
| 2 |
Adobe
ADBE
|
$85.2K |
| 3 |
Steris
STE
|
$78.2K |
| 4 |
Neurocrine Biosciences
NBIX
|
$64.8K |
| 5 |
CVS Health
CVS
|
$62.9K |
Sector Composition
| 1 | Technology | 30.09% |
| 2 | Industrials | 22.23% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.68% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
126
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $23.1K | 0.15% |
1,250,000
-250,000
| -17% | -$4.63K |
|
127
SiTime
SITM
$6.1B
| $23.1K | 0.15% |
293,188
-93,308
| -24% | -$7.35K |
|
128
Alnylam Pharmaceuticals
ALNY
$59.2B
| $23K | 0.15% |
115,000
-98,079
| -46% | -$19.6K |
|
129
Pliant Therapeutics
PLRX
$114M
| $23K | 0.15% |
+1,100,000
| New | +$23K |
|
130
AtriCure
ATRC
$1.76B
| $22.4K | 0.14% |
573,345
+44,487
| +8% | +$1.74K |
|
131
Ametek
AME
$43.3B
| $21.9K | 0.14% |
193,129
-1,352
| -0.7% | -$153 |
|
132
Alcon
ALC
$39.6B
| $21.7K | 0.14% |
356,621
-6,203
| -2% | -$378 |
|
133
Intuitive Surgical
ISRG
$167B
| $21.7K | 0.14% |
115,528
+19,289
| +20% | +$3.62K |
|
134
Intercontinental Exchange
ICE
$99.8B
| $21.4K | 0.14% |
237,169
-1,661
| -0.7% | -$150 |
|
135
Wells Fargo
WFC
$253B
| $21.3K | 0.14% |
529,373
+100,716
| +23% | +$4.05K |
|
136
Humana
HUM
$37B
| $20.8K | 0.13% |
42,921
+5,921
| +16% | +$2.87K |
|
137
Shopify
SHOP
$191B
| $20.6K | 0.13% |
763,986
-106,874
| -12% | -$2.88K |
|
138
Centene
CNC
$14.2B
| $19.9K | 0.13% |
255,399
+6,028
| +2% | +$469 |
|
139
Cenovus Energy
CVE
$28.7B
| $19.2K | 0.12% |
1,016,844
-4,243
| -0.4% | -$80 |
|
140
Canadian Natural Resources
CNQ
$63.2B
| $19.2K | 0.12% |
670,236
-42,834
| -6% | -$1.23K |
|
141
BioMarin Pharmaceuticals
BMRN
$11.1B
| $19.1K | 0.12% |
225,000
| – | – |
|
142
Ovintiv
OVV
$10.6B
| $18.8K | 0.12% |
407,854
+35,000
| +9% | +$1.61K |
|
|
143
Neurocrine Biosciences
NBIX
$14.3B
| $18.5K | 0.12% |
173,946
-610,341
| -78% | -$64.8K |
|
144
Adicet Bio
ACET
$60M
| $18.4K | 0.12% |
1,293,670
-250,000
| -16% | -$3.56K |
|
145
LPL Financial
LPLA
$26.6B
| $18.3K | 0.12% |
83,673
-36,589
| -30% | -$7.99K |
|
146
Fiserv
FI
$73.4B
| $18K | 0.11% |
192,538
+34,600
| +22% | +$3.24K |
|
147
AptarGroup
ATR
$9.13B
| $18K | 0.11% |
189,372
-285,351
| -60% | -$27.1K |
|
148
Rhythm Pharmaceuticals
RYTM
$6.78B
| $17.5K | 0.11% |
+714,739
| New | +$17.5K |
|
149
SS&C Technologies
SSNC
$21.7B
| $17.1K | 0.11% |
357,375
-40,385
| -10% | -$1.93K |
|
150
Service Corp International
SCI
$10.9B
| $16.9K | 0.11% |
291,821
-58,598
| -17% | -$3.38K |
|